The global cell-based assay market is anticipated to grow at a considerable CAGR of 7.7% during the forecast period. The increasing technological-based advancement by key players operating in the market and various approvals for assays-based products are key factors that are propelling the market growth. The companies are investing in the development of new and technology-based products such as AI, Cloud-based new products, and other technologies that are fulfilling the increasing demand by the end-user of the market. For instance,
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-based-assay-market
- In August 2022, Predicine company launched its CE-marked “PredicineCARE” liquid biopsy assay in Europe which is to target 152 genes in patients diagnosed with cancer. This liquid biopsy assay has been used in patient testing, clinical trials, and in the development of companion diagnostics.
- In March 2022, CELLINK, a BICO Company, launched BIO CELLX, to eliminate barriers to automating 3D cell-based assays targeting cancer research and drug discovery. This new system that automates 3D cell culture workflows is built upon CELLINK’s impressive bioprinting portfolio which utilizes many proven technologies. The new system was selected as a finalist for the New Product Award at the recent SLAS conference in Boston.
- In February 2021, Axion BioSystems has launched Maestro ZHT a screening platform, to add a new dimension to drug discovery and development by leveraging their expertise in live-cell instrumentation. This new platform meets all the changes such as reducing cost, time, and waste of precious antibodies and cells with an easy, automated, real-time, live-cell assay.
Global Cell-based Assays Market Report Segment
By Product
- Consumables
o Reagents
o Cell Lines
o Microplates
o Probes & Labels
- Instruments
- Service
- Software
By Application
- Drug Discovery
- Basic Research
- ADME Studies
- Predictive Toxicology
By End-User
- Contract Research Organizations
- Academic and Government Institutions
- Pharmaceutical and Biotechnology Companies
A full report of Cell-based Assays Market is available at: https://www.omrglobal.com/industry-reports/cell-based-assay-market
Cell-based Assays Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AAT Bioquest, Inc.
- Altis Biosystems, Inc.
- Apical Scientific Sdn Bhd
- Axion BioSystems Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Co..
- BioAgilytix
- Cell Signaling Technology, Inc.
- Charles River Laboratories
- Eurofins DiscoverX Products, LLC
- Genesis Biotechnology Group, LLC
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
